Protide Pharmaceuticals Inc (PPMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 02-2004 | 11-2003 | 08-2003 | 05-2003 | 02-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 110 | 80 | N/A | 140 | 160 |
| Marketable Securities | 70 | 80 | N/A | 80 | 80 |
| Receivables | 70 | 50 | N/A | 40 | 50 |
| Inventories | 40 | 40 | N/A | 60 | 60 |
| Other current assets | 10 | 10 | 0 | 10 | 10 |
| TOTAL | $300 | $260 | $N/A | $330 | $360 |
| Non-Current Assets | |||||
| PPE Net | N/A | 460 | N/A | 460 | 460 |
| Other Non-Current Assets | 30 | 40 | 0 | 40 | 40 |
| TOTAL | $30 | $500 | $N/A | $500 | $500 |
| Total Assets | $350 | $320 | $N/A | $400 | $440 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10 | 4 | 0 | 10 | 10 |
| Accrued Expenses | 30 | 20 | N/A | 30 | 30 |
| TOTAL | $110 | $100 | $N/A | $110 | $110 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $110 | $100 | $N/A | $110 | $110 |
| Shareholders' Equity | |||||
| Common Shares | 40 | 40 | N/A | 40 | 40 |
| Retained earnings | -5,630 | -5,650 | N/A | -5,570 | -5,540 |
| Other shareholders' equity | 0 | -10 | 0 | -10 | -10 |
| TOTAL | $240 | $210 | $N/A | $290 | $320 |
| Total Liabilities And Equity | $350 | $310 | $0 | $400 | $430 |